DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Michael Melgar - 3 Rochelle Walensky - 2 That's - 1 Melgar - 1
Top related locs:
U.S Los Angeles United States
Top related orgs:
Pfizer - 3 GSK - 3 CDC - 2 Centers for Disease Control - 2 Disease Control - 1 U.S . Food - 1 Drug Administration - 1 Spokespeople - 1

Search resuls for: "Michael Melgar"


3 mentions found


☆ CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
  + stars: | 2023-06-29 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +2 min
The Centers for Disease Control and Prevention on Thursday recommended that adults ages 60 and above receive a single dose of RSV vaccines from Pfizer and GSK after consulting their doctors. "These vaccines provide an opportunity to help protect older adults against severe RSV illness at a time when multiple respiratory infections are likely to circulate," the CDC said in a statement. The virus is a common respiratory infection that usually causes mild, cold-like symptoms, but more severe cases in older adults and children. Each year, RSV kills 6,000 to 10,000 seniors and a few hundred children younger than 5, according to CDC data. But the panel raised concerns about the lack of efficacy data on subgroups of the elderly population at the highest risk of severe RSV.
Persons: Rochelle Walensky, Michael Melgar Organizations: Disease Control, Pfizer, GSK, CDC, U.S . Food, Drug Administration, Spokespeople Locations: U.S
☆ Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
  + stars: | 2023-06-22 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +2 min
Vaccinating one million adults ages 65 and above with a single RSV shot from Pfizer or GSK may prevent thousands of hospitalizations over two seasons of the virus, according to a Centers for Disease Control and Prevention analysis. The committee recommended that adults ages 60 and older may receive one dose of Pfizer's or GSK's respiratory syncytial virus shot after consulting their doctor. The analysis also found that vaccinating one million adults in the same age group with one dose of GSK's shot may prevent roughly 2,300 hospitalizations and 23,000 outpatient visits. Each year, RSV hospitalizes 60,000 to 160,000 older adults and kills 6,000 to 10,000, according to CDC data. Last year, cases of RSV – along with Covid and the flu – in children and older adults overwhelmed hospitals across the nation.
Persons: Michael Melgar Organizations: Pfizer, GSK, Centers for Disease Control, University of Michigan, Northern Hemisphere
☆ CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults 60 and older
  + stars: | 2023-06-21 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +3 min
The virus is a common respiratory infection that usually causes mild, cold-like symptoms, but more severe cases in older adults and children. Pfizer and GSK on Wednesday both presented new clinical trial data to the panel, which provided a first glimpse of their shots' durability after one RSV season. That's down from more than 85% at the end of the first season in older adults. For less severe RSV disease, efficacy declined to 67.2% over two seasons from 82% after one season. The shots would help the U.S. combat the upcoming RSV season in the fall after an unusually severe RSV season last year.
Persons: Rochelle Walensky, That's, Michael Melgar, Melgar Organizations: Centers for Disease Control, Pfizer, GSK, Food and Drug Administration, CDC, Northern, Seniors Locations: Los Angeles, United States
0 next >>
Total: 3